Metformin and Pancreatic Cancer Survival

Metformin offers no survival advantage in patients with metastatic pancreatic cancer. Despite promising experimental evidence suggesting an antitumor effect of metformin, its impact on the survival of advanced pancreatic cancer is likely very limited. Future studies may need to consider its role in early-stage pancreatic cancer. Clin Cancer Res; 22(5); 1031–3. ©2015 AACR.

See related article by Reni et al., p. 1076

from #Medicine-SfakianakisAlexandros via o.lakala70 on Inoreader http://ift.tt/1QIRqg1
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1RDS01T
via IFTTT